OnKure Therapeutics OKUR Income Statement (2020-2026)

NASDAQ OKUR
$3.36 -0.03 (-0.74%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

OnKure Therapeutics Quarterly Income Statement

Periods 27 quarters
Latest Sep 2026

OnKure Therapeutics reported revenue of $1.50M and net income of -$17.86M for the quarter ended Sep 2026, up 87.7% year over year. This income statement covers 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
0.20M-0.04M1.20M1.08M0.93M0.80M0.62M0.46M1.55M1.51M
Operating items
Research & DevelopmentR&D
7.10M9.28M8.13M9.94M10.36M10.99M14.40M13.62M-6.89M8.57M10.75M10.12M14.36M13.01M12.61M11.92M10.72M11.71M12.61M15.06M
Share-based Compensation (IS)Stock Comp.
0.11M2.75M
Selling, General & AdministrativeSG&A
3.52M3.74M4.30M3.90M4.21M5.13M6.64M7.27M-14.22M1.27M3.59M1.40M4.34M3.99M3.71M3.59M3.41M3.91M4.29M4.29M
Operating ExpensesOpex
10.62M13.02M12.43M13.84M14.56M16.12M21.04M20.89M-21.11M9.83M14.34M11.51M18.70M17.00M16.32M15.50M14.13M15.62M16.90M19.35M
Operating IncomeOp. Inc
-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.34M-11.51M-18.70M-17.00M-16.32M-15.50M-14.13M-15.62M-16.90M-19.35M
Non-operating items
Non Operating Interest Expenses
0.03M0.22M0.06M0.00M0.01M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
0.02M0.03M0.10M-0.19M-0.02M0.06M-0.04M0.01M0.03M-0.02M0.00M0.02M-0.01M-0.02M
Other Non Operating IncomeOther Non Op Inc.
0.02M-0.02M0.12M0.83M0.96M1.02M1.51M1.69M1.45M1.14M1.00M0.97M
Non Operating IncomeNon Op. Inc.
-0.04M1.26M1.08M0.93M0.80M0.62M0.46M1.55M1.51M
Net income details
EBIT
-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.34M-11.51M-18.70M-17.00M-16.32M-15.50M-14.13M-15.62M-16.90M-19.35M
EBT
-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.37M-11.73M-18.76M-17.00M-16.32M-15.50M-14.13M-15.62M-16.90M-19.35M
Income After Tax
-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.37M-11.73M-18.76M-17.00M-16.32M-15.50M-14.13M-15.62M-16.90M-19.35M
Income from Continuing OperationsIncome (Continuing)
-10.62M-13.02M-12.43M-13.84M-14.56M-16.12M-21.04M-20.89M21.11M-9.83M-14.37M-11.73M-18.76M-17.00M-16.32M-15.50M-14.13M-15.62M-16.90M-19.35M
Consolidated Net IncomeConsol Net Inc.
-10.59M-13.01M-12.21M-13.20M-13.62M-15.05M-19.57M-19.19M-23.53M-8.45M-5.36M-3.68M-18.76M-17.00M-15.39M-14.70M-14.13M-15.62M-15.36M-17.86M
Income towards Parent CompanyParent Net Inc
-10.61M-13.04M-12.31M-13.01M-13.60M-15.11M-19.53M-19.20M18.52M-9.54M-14.14M-11.56M-17.44M-15.93M-15.39M-14.70M-13.50M-15.16M-15.35M-17.85M
Net Income towards Common StockholdersNet Income
-10.61M-13.04M-12.31M-13.01M-13.60M-15.11M-19.53M-19.20M18.52M-9.54M-14.14M-11.56M-17.44M-15.93M-15.39M-14.70M-13.50M-15.16M-15.35M-17.85M
Additional items
EPS (Basic)
-5.85-5.33-5.03-5.31-5.55-6.03-6.46-5.686.04-2.85-4.23-3.46-5.06-1.19-1.14-1.09-1.00-1.11-0.31-0.36
EPS (Diluted)
-5.85-5.33-5.03-5.31-5.55-6.03-6.46-5.686.04-2.85-4.23-3.46-5.06-1.19-1.14-1.09-1.00-1.11-0.31-0.36
Shares Outstanding
1.81M2.45M2.45M2.45M2.45M2.50M3.02M3.38M3.07M3.34M3.34M3.34M3.45M13.42M13.51M13.53M13.52M13.67M49.87M49.93M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
1.81M2.45M2.45M2.45M2.45M2.50M3.02M3.38M3.07M3.34M3.34M3.34M3.45M13.42M13.51M13.53M13.52M13.67M49.87M49.93M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
1.81M2.45M2.45M2.45M2.47M13.34M13.34M13.34M13.34M13.34M13.34M13.34M13.35M12.76M12.84M12.86M13.67M13.67M40.50M40.50M
EBITDA
-10.61M-13.00M-12.41M-13.82M-14.54M-16.08M-21.00M-20.85M21.40M-9.72M-14.23M-11.27M-18.57M-16.88M-16.21M-15.39M-14.02M-15.51M-16.81M-19.30M
Interest ExpensesInt Expense
0.03M0.22M0.06M0.00M0.01M

OnKure Therapeutics Income Statement API

Pull OnKure Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OKUR&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY